182 related articles for article (PubMed ID: 35032181)
1. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
[TBL] [Abstract][Full Text] [Related]
2. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
[TBL] [Abstract][Full Text] [Related]
3. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
[TBL] [Abstract][Full Text] [Related]
4. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Tan RZH; Lockart I; Abdel Shaheed C; Danta M
Aliment Pharmacol Ther; 2021 Aug; 54(4):356-367. PubMed ID: 34247393
[TBL] [Abstract][Full Text] [Related]
6. Aspirin Use and the Risk of Hepatocellular Carcinoma: A Meta-analysis.
Wang Y; Wang M; Liu C; Wang W; Shi J; Dang S
J Clin Gastroenterol; 2022 Aug; 56(7):e293-e302. PubMed ID: 35316225
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
[TBL] [Abstract][Full Text] [Related]
8. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
[TBL] [Abstract][Full Text] [Related]
9. Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B.
Lee TY; Hsu YC; Tseng HC; Yu SH; Lin JT; Wu MS; Wu CY
JAMA Intern Med; 2019 May; 179(5):633-640. PubMed ID: 30882847
[TBL] [Abstract][Full Text] [Related]
10. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
[TBL] [Abstract][Full Text] [Related]
11. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Yu Y; Liu L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
[TBL] [Abstract][Full Text] [Related]
12. Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Lee TY; Hsu YC; Tseng HC; Lin JT; Wu MS; Wu CY
Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2784-2792.e7. PubMed ID: 32360983
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis.
Abdelmalak J; Tan N; Con D; Eslick G; Majeed A; Kemp W; Roberts SK
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444628
[TBL] [Abstract][Full Text] [Related]
14. Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
Liu Y; Ren T; Xu X; Jin J
Eur J Cancer Prev; 2022 Jan; 31(1):35-43. PubMed ID: 33470689
[TBL] [Abstract][Full Text] [Related]
15. Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality.
Simon TG; Duberg AS; Aleman S; Chung RT; Chan AT; Ludvigsson JF
N Engl J Med; 2020 Mar; 382(11):1018-1028. PubMed ID: 32160663
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
17. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
[No Abstract] [Full Text] [Related]
18. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
Bian W; Bian W; Li Q; Li Y
J Gastrointest Cancer; 2024 Apr; ():. PubMed ID: 38557825
[TBL] [Abstract][Full Text] [Related]
19. Combined Use of Aspirin and Statin is Associated With a Decreased Incidence of Hepatocellular Carcinoma.
Singh J; Wozniak A; Cotler SJ; Dhanarajan A; Aldrich D; Park D; Kasia C; Schmidt B; Scaglione S
J Clin Gastroenterol; 2022 Apr; 56(4):369-373. PubMed ID: 33883511
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis.
Yan LJ; Yao SY; Li HC; Meng GX; Liu KX; Ding ZN; Hong JG; Chen ZQ; Dong ZR; Li T
J Clin Transl Hepatol; 2022 Oct; 10(5):835-846. PubMed ID: 36304506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
